Your session is about to expire
← Back to Search
rTMS for Suicidal Ideation in Opioid Users
Study Summary
This trial is investigating if a treatment targeting the OFC/dSTR connectivity will reduce compulsive reward-seeking behavior in patients with a history of opioid abuse and suicidal ideation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have previously participated in a trial called H-22611.You understand the consent form, can provide your consent in writing, and agree to complete all study procedures.You are eligible for TMS treatment, as long as you do not have any metal in your head or within 12 inches of the TMS coil.You have a high score on a test that measures your use of drugs like opioids, indicating that you may have a substance abuse problem.You are currently receiving treatment at The Menninger Clinic.I am between 18 and 60 years old.You can safely undergo an MRI scan without any metal objects in your body that could cause harm or interfere with the scan. You also need to pass some initial questions to make sure you are a good candidate for an MRI.I am not pregnant or breastfeeding.You have current thoughts of hurting yourself, according to a questionnaire.You are experiencing symptoms of depression as determined by the PHQ-9 questionnaire.
- Group 1: Sham rTMS
- Group 2: Active rTMS
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who meets the criteria for enrollment in this medical trial?
"This clinical trial seeks 80 adults of both genders between 18 and 64 years old, who demonstrate depressive symptoms according to the Patient Health Questionnaire (PHQ)-9; have active suicidal ideation as evidenced by their Suicide Behaviors Questionnaire-Revised (SBQ-R) scores; are presently enrolled in The Menninger Clinic, possess sufficient comprehension of the consent form and provide written informed consent for study procedures. Female subjects must be non-nursing and not pregnant at times of fMRI experiments and rTMS treatment. Additionally, they cannot present with any MRI or TMS contraindications such as pacem"
Are there still opportunities for potential participants to join the study?
"The clinical trial is actively seeking participants, as evidenced by the information available on clinicaltrials.gov. The first post regarding this study was made on April 1st 2022 with the most recent update being August 3rd of that same year."
What is the sample size for this investigative research?
"Affirmative. Clinicaltrials.gov details that this research is proactively seeking participants, having been first posted on April 1st 2022 and last refreshed on August 3rd 2022. The study requires 80 individuals to be recruited from one site."
Does this experiment include participants beyond a certain age?
"This clinical trial is looking for individuals aged 18-64 to participate as study participants."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
How responsive is this trial?
Typically responds via
Most responsive sites:
- The Menninger Clinic: < 24 hours
Average response time
- < 1 Day
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger